RT Journal Article
SR Electronic
T1 45 An integrative immune signature of complementary circulating and tumoral biomarkers maximizes the predictive power of adjuvant immunotherapeutic benefits for high-risk melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A52
OP A52
DO 10.1136/jitc-2023-SITC2023.0045
VO 11
IS Suppl 1
A1 Tarhini, Ahmad A
A1 Obermayer, Alyssa
A1 Lee, Sandra J
A1 LaFramboise, William A
A1 Stephen Hodi, F
A1 Karunamurthy, Arivarasan D
A1 Hwu, Patrick
A1 Chen, Dung-tsa
A1 Naqa, Issam El
A1 Streicher, Howard
A1 Storkus, Walter J
A1 Butterfield, Lisa H
A1 Kirkwood, John M
A1 Shaw, Timothy I
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A52.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.